CAS (Cold Agglutinin Syndrome) is a new term (new to us) that surfaced in some medical research documentation 2021 we were sifting through.
We are under the impression this is being used interchangeably for what many of us long term CADs have always referred to as “Secondary CAD“.
This differs from “Primary CAD“.
